Shuling Zhang

机构：Qilu University of Technology, Shandong Academy of Sciences · ORCID：0009-0006-4314-9691

发表论文 111 篇 · 总被引 1826 次 · h-index 24

代表论文

• Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review (2020 · Frontiers in Oncology · 被引 86)
• Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells (2024 · Molecular Cancer · 被引 79)
• Biological effects of IL-15 on immune cells and its potential for the treatment of cancer (2020 · International Immunopharmacology · 被引 77)
• Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials (2021 · Frontiers in Oncology · 被引 66)
• Impact of EGFR exon 19 deletion subtypes on clinical outcomes in EGFR-TKI-Treated advanced non-small-cell lung cancer (2022 · Lung Cancer · 被引 42)
• Methionine enkephalin (MENK) suppresses lung cancer by regulating the Bcl-2/Bax/caspase-3 signaling pathway and enhancing natural killer cell-driven tumor immunity (2021 · International Immunopharmacology · 被引 34)